Brickell Biotech, Inc.   (NASDAQ:BBI)

0.16    $-0.01   -3.03%
Market open   Sunday, May 22 2022 12:55 PM

Brickell Biotech, Inc. Chart

BBI Stock Price Today

Brickell Biotech, Inc. (BBI) stock plummeted over -3.03% intraday to trade at $0.16 a share on NASDAQ. The stock opened with a gain of 0.00% at $0.17 and touched an intraday high of $0.18, rising 5.88% against the last close of $0.17. The stock went to a low of $0.16 during the session.

Stock Snapshot

0.17
Prev. Close
0.17
Open
21.65M
Market Cap
119.38M
Number of Shares
0.16
day Low
0.18
Day High
0.16
-
P/E ratio
3.57%
Free Float in %
-0.42
EPS (TTM)
0.13
Book Value per Share
0.13
Cash Flow per Share
8.05M
Volume

Brickell Biotech, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2022-05-20$0.17$0.16$0.18$0.168,056,300
2022-05-19$0.17$0.17$0.17$0.162,633,000
2022-05-18$0.18$0.17$0.18$0.172,646,400
2022-05-17$0.19$0.18$0.20$0.182,799,200
2022-05-16$0.19$0.19$0.21$0.183,392,300
2022-05-13$0.19$0.19$0.21$0.195,841,200
2022-05-12$0.20$0.21$0.22$0.193,022,000
2022-05-11$0.23$0.20$0.23$0.203,782,400
2022-05-10$0.21$0.21$0.23$0.213,234,400
2022-05-09$0.23$0.21$0.23$0.203,938,800
2022-05-06$0.23$0.23$0.24$0.232,797,100

Contact Details

5777 Central Avenue
Suite 102
Boulder, CO 80301
United States
https://www.brickellbio.com
720 505 4755

Company Information

Employees13
Beta0.10
Sales or Revenue400000.00
5Y Sales Change-51.20%
Fiscal Year Ends2021-12-30
SectorHealthcare
IndustryBiotechnology

About Company

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.

Frequently Asked Questions

What is the current Brickell Biotech, Inc. (BBI) stock price?

Brickell Biotech, Inc. (NASDAQ: BBI) stock price is $0.16 as of the last check on Sunday, May 22 2022. During the trading session, BBI stock reached the peak price of $0.18 while $0.16 was the lowest point it dropped to.

BBI's industry and sector of operation?

The NASDAQ listed BBI is part of Biotechnology industry that operates in the broader Healthcare sector. Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States.

Who are the executives of BBI?

Mr. Reginald L. Hardy M.B.A., R.Ph.
Co-Founder & Chairman

Attorney Robert Busard Brown
CEO & Director

Mr. Andrew D. Sklawer
Co-Founder, COO & Sec.

Mr. Albert Nicholas Marchio II
Chief Financial Officer


What is the BBI stock price today?

BBI stock is trading at $0.16 today, which is $-0.01 or -3.03% lower than its previous close of $0.17. BBI's current trading price is -84.33% lower than its 52-week high of $1.04 where as its distance from 52-week low of $0.16 is 3.03%.

How many employees does BBI have?

Number of BBI employees currently stands at 13. BBI operates from 5777 Central Avenue
Suite 102
Boulder, CO 80301
United States.

Link for BBI official website?


How do I contact BBI?

BBI could be contacted at 5777 Central Avenue
Suite 102
Boulder, CO 80301
United States, or at phone # 720 505 4755 and can also be accessed through its website: https://www.brickellbio.com

How many shares of BBI are traded daily?

BBI stock volume so far today is 8.05M shares while in the previous session number of BBI shares traded was 8.06M. The average number of BBI shares traded daily for last 3 months was 5.49M.

How much did BBI change today?

The percentage change in BBI stock occurred in the recent session was -3.03% while the dollar amount for the price change in BBI stock was $-0.01.

What price range BBI stock been trading in?

In the recent session, the day high for BBI stock was $0.18 while the low for BBI stock touched on the day was $0.16.

What is the market cap of BBI currently?

The market value of BBI currently stands at $21.65M with its latest stock price at $0.16 and 119.38M of its shares outstanding.